Cardiovascular involvement in ANCA-associated vasculitis
Nephrology Dialysis Transplantation · 26.11.2025 · 40 (12) · 2256-2267
DOI: 10.1093/ndt/gfaf070 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 25.04.2025. Verfasst von Ahmad Sarmad und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Loma Linda University, Loma Linda, CA, USA. Hauptthemen laut MEDLINE: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Cardiovascular Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Abstract (Originalsprache)
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a systemic necrotizing vasculitis with significant cardiovascular involvement, primarily manifesting in granulomatosis with polyangiitis, microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis. AAV patients face a 65% higher cardiovascular event risk, with common manifestations such as myocardial infarction, stroke and myocarditis, and less frequently, aortitis. Pathophysiology includes endothelial dysfunction, vascular inflammation, and direct inflammatory infiltration of cardiac tissue, exacerbated by traditional risk factors such as hypertension and dyslipidemia, and non-traditional factors like immunosuppressive therapies. Management emphasizes cardiovascular risk reduction through traditional methods alongside cautious use of glucocorticoids and immunosuppressants to control disease activity and minimize cardiovascular impact. Despite therapeutic advancements, long-term cardiovascular morbidity and mortality risks persist, underscoring the need for enhanced predictive tools and individualized therapeutic strategies. We aim to review current literature on the incidence, clinical manifestations and outcomes of cardiovascular involvement in AAV, with a focus on pathophysiology, risk factors, predictive models, and strategies for prevention and management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Loma Linda University, Loma Linda, CA, USA.
- Department of Medicine, Division of Nephrology, Loma Linda University, Loma Linda, CA, USA.
- Department of Medicine, Nephrology Division, Medical College of Wisconsin, Milwaukee, WI, USA.
- Department of Internal Medicine IV, Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria.
- Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
- Division of Nephrology, Johns Hopkins University, Baltimore, MD, USA.
ORCID-Profile: Zohreh Gholizadeh Ghozloujeh, Paul E Hanna, Roy Mathew
Zitieren
APA
Sarmad, A., Gholizadeh Ghozloujeh, Z., Hanna, P. E., Kronbichler, A., Geetha, D., Heidari-Bateni, G., Mathew, R., Ahmad, M., Mohammed, A., Siddiqui, S., Abdipour, A., & Norouzi, S. (2025). Cardiovascular involvement in ANCA-associated vasculitis. Nephrology Dialysis Transplantation, 40(12), 2256-2267. https://doi.org/10.1093/ndt/gfaf070
Vancouver
Sarmad A, Gholizadeh Ghozloujeh Z, Hanna PE, Kronbichler A, Geetha D, Heidari-Bateni G, et al. Cardiovascular involvement in ANCA-associated vasculitis. Nephrology Dialysis Transplantation. 2025;40(12):2256-2267. doi:10.1093/ndt/gfaf070
BibTeX
@article{Sarmad2025,
author = {Sarmad, Ahmad and Gholizadeh Ghozloujeh, Zohreh and Hanna, Paul E and Kronbichler, Andreas and Geetha, Duvuru and Heidari-Bateni, Giv and Mathew, Roy and Ahmad, Muhammad and Mohammed, Afnan and Siddiqui, Samrah and Abdipour, Amir and Norouzi, Sayna},
title = {Cardiovascular involvement in ANCA-associated vasculitis},
journal = {Nephrology Dialysis Transplantation},
year = {2025},
volume = {40},
number = {12},
pages = {2256--2267},
doi = {10.1093/ndt/gfaf070}
}
EUVIMED